Article
The effect of dulaglutide on glycated hemoglobin is associated with PNPLA3 Ι148Μ gene polymorphism in patients with type 2 diabetes mellitus.
Endocrine - 1 Jan 2025
Gavriilidis Stylianos, Andrianopoulou Rozalia, Ntenti Charikleia, Sarakapina Anna, Trakatelli Christina, Polyzos Stergios A, Goulas Antonis
Abstract excerpt
PURPOSE: The evaluation of the effect of dulaglutide on glycated hemoglobin (HbA1c) and non-invasive indices of hepatic steatosis among different genotypes of the PNPLA3 I148M (rs738409) and CETP Taq1B (rs708272) polymorphisms in patients with type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD). METHODS: Relevant data from patients with inadequately controlled T2DM, also displaying...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
